METTL1‐Mediated M <sup>7</sup> G tRNA Modification Promotes Residual Liver Regeneration After Hepatectomy via Translational Control
Partial hepatectomy (PHx) has emerged as a primary therapeutic intervention for end-stage liver pathologies. However, post-hepatectomy liver failure (PHLF), a critical complication arising from inadequate regenerative capacity of the remnant liver, underscores the clinical imperative to understand molecular mechanisms governing hepatic regeneration. Through an integrative multi-omics analysis in a murine 70% PHx model coupled with clinical correlation studies, the tRNA m<sup>7</sup>G methyltransferase METTL1 was identified as a pivotal regulator of post-resection hepatic recovery. METTL1 exhibited significant temporal upregulation following PHx, with its expression profile positively correlating with favorable clinical outcomes in surgical patients. Genetic ablation of METTL1 substantially attenuated hepatocyte proliferation and compromised regenerative capacity, whereas its ectopic expression potentiated liver regeneration through enhanced translational efficiency. Mechanistic investigations revealed that METTL1-mediated m<sup>7</sup>G tRNA modification orchestrates regenerative processes by selectively augmenting the translation of Hippo pathway effectors YAP/TAZ. Most importantly, modulation of the METTL1-YAP/TAZ signaling axis successfully promotes liver regeneration after PHx. This study elucidates a previously unrecognized translational control mechanism underlying liver regeneration, proposing METTL1 as a promising molecular target for preventing PHLF through therapeutic enhancement of hepatic regenerative potential.
Authors
- Manling Huang (ORCID: https://orcid.org/0000-0003-0098-7928)
- Zimin Song (ORCID: https://orcid.org/0000-0002-0302-3502)
- Dongmei An (ORCID: https://orcid.org/0000-0003-4622-0837)
- Yu Guo (ORCID: https://orcid.org/0000-0002-8886-0106)
- Zixin Huang (ORCID: https://orcid.org/0000-0002-4057-061X)
- Xin Yu (ORCID: https://orcid.org/0000-0003-0543-5567)
- Ming Kuang (ORCID: https://orcid.org/0000-0003-0131-4848)
- Yutong Zhao (ORCID: https://orcid.org/0000-0001-9766-0459)
- Shuirong Lin
- Yunpeng Hua (ORCID: https://orcid.org/0000-0003-4814-9392)
- Shunli Shen (ORCID: https://orcid.org/0000-0002-3133-3508)
- Yifan Zhang
- Fang Wang (ORCID: https://orcid.org/0000-0002-9715-1838)
- Weiwei Wang (ORCID: https://orcid.org/0000-0002-6743-4511)
- Jing Wang (ORCID: https://orcid.org/0000-0002-0398-862X)
- Jiale Chen (ORCID: https://orcid.org/0000-0002-2980-2037)
- Linyuan Huang
- Yuyao Liu (ORCID: https://orcid.org/0009-0007-5443-9480)
Institutions
- Sun Yat-sen University (CN)
- Meizhou City People's Hospital (CN)
- The First Affiliated Hospital, Sun Yat-sen University (CN)
- Sun Yat-sen University Cancer Center (CN)
Publication Details
- Journal
- Advanced Science
- Published
- 2025-12-08
- DOI
- https://doi.org/10.1002/advs.202507329
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00